Pfizer Makes Progress on Multiple Fronts with COVID-19 Treatment Candidate
Pfizer’s oral COVID-19 treatment has been authorized by the U.S. Food and Drug Administration (FDA) as well as numerous other governments around the world.
Two Billion Doses by the End of 2022: Pfizer’s Commitment to Equitable Access
To truly enter a post-pandemic world, scientists estimate that up to 70 percent of the global population will need to develop immunity, either through vaccination or by recovering from infection.
A Pill That Could Potentially Save Lives: Pfizer Treatment Reduced Risk of Hospitalization or Death from COVID-19 in Interim Analysis
Pfizer’s investigational novel COVID-19 oral antiviral candidate, PAXLOVID ™ (PF-07321332; ritonavir), reduced the risk of COVID-19-related hospitalization or death from any cause by 89 percent.
CEO Albert Bourla on Transforming Pfizer
"When the pandemic hit, I knew that we had to act. I thought ‘if not us, then who?'"
Pfizer Inc. Third Quarter 2021 Financial Results
Pfizer Inc. (NYSE: PFE) reported financial results for third quarter 2021 and raised 2021 guidance for revenues and Adjusted diluted EPS.
A Potential Breakthrough in the Fight Against RSV? Pfizer’s Vaccine Candidate Enters Phase 3 Trials
Every fall, the classic symptoms appear as the temperature drops. A runny nose. Coughing. Sneezing. A fever.
What Can You Tell Me About Potential COVID-19 Vaccines in Children? Hear About Some of Pfizer’s Research
Pfizer has been working to determine and evaluate the preferred vaccine dose to provide protection against COVID-19 in children.
Shot of a Lifetime: How Pfizer and BioNTech Developed and Manufactured a COVID-19 Vaccine in Record Time
Inside Pfizer, it was dubbed “Project Light Speed,” and its purpose was to make the impossible possible: produce a vaccine by the end of the year.
The Company You Keep: Pfizer Partners for Success
Pfizer partners with a wide array of innovators, from biopharmaceutical companies pushing the frontier of cancer therapy research to artificial intelligence companies that are discovering novel ways to create new medicines.